• SENSEX
    NIFTY 50

Here's why Lupin is best bet to play diabetes story in India over next 2-3 yrs, says Edelweiss Securities

Updated : December 20, 2019 12:35 PM IST

Most of Sun Pharma's USFDA observations are procedural in nature.
See approval of Ryaltris as decent opportunity for Glenmark.
Published : December 20, 2019 12:35 PM IST

You May Also Like

Live TV

recommended for you

Advertisement